← Leaderboards
Salvatore V Pizzo
Duke University
$13,358,085
Attributed
$14,500,119
Total exposure
7
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,500,119 · 7
By mechanism
T32$8,551,013 · 1
R01$4,420,224 · 3
U01$565,250 · 1
R37$501,632 · 1
R21$462,000 · 1
Top collaborators
- Stephen Jay Freedland5 shared
- Chang-Lung Lee1 shared
- Manisha Palta1 shared
Most similar at Duke University
Same institution · by research overlap
- Nelson J. Chao$27,968,804
- John P Chute$16,426,438
- Andrea M Haqq$636,625
- Martin P Tornai$4,591,354
- Jeffrey M Greeson$907,680
Others in their field
Top investigators on “Monoclonal Antibody”
- Bambra Strokes · Ppd Development Lp$461,655,950
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$276,346,332
- Lawrence Corey · Fred Hutchinson Cancer Center$271,417,082
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$257,261,947
- Peter B. Gilbert · Fred Hutchinson Cancer Center$190,281,881
- Barton F Haynes · Duke University$125,632,198
Research focus
Monoclonal AntibodyClinical ResearchEnzyme ActivityNeutralizing AntibodyScid MouseCancer TherapyIn VivoMorbidity - Disease RatePreventNucleoside Diphosphate KinaseLaboratory RabbitCessation Of LifeNeoplasm /Cancer ImmunotherapyMacroglobulinsProteinsDoseIn VitroAnimalsCarbohydratesCaringBaseAngiostatinsCancer TypeCell Migration
Grant awards (26)
Serum pro-N-cadherin as an early biomarker of radiation-induced heart disease$565,250
U01 · FY2025 · AI
Resveratrol, Carbohydrate Restriction and Prostate Cancer Progression$300,504
R01 · FY2012 · CA
Resveratrol, Carbohydrate Restriction and Prostate Cancer Progression$300,504
R01 · FY2011 · CA
Resveratrol, Carbohydrate Restriction and Prostate Cancer Progression$309,798
R01 · FY2010 · CA
Resveratrol, Carbohydrate Restriction and Prostate Cancer Progression$309,798
R01 · FY2009 · CA
Resveratrol, Carbohydrate Restriction and Prostate Cancer Progression$309,798
R01 · FY2008 · CA
Cell Receptors In Coagulation And Atherogenesis$300,762
R01 · FY2006 · HL · contact PI
Medical Scientist Training Program$1,534,742
T32 · FY2005 · GM
Modulation of Angiogenesis Via the Angiostatin Receptor$328,765
R01 · FY2005 · CA
Cell Receptors In Coagulation And Atherogenesis$308,000
R01 · FY2005 · HL
Medical Scientist Training Program$1,578,591
T32 · FY2004 · GM
Modulation of Angiogenesis Via the Angiostatin Receptor$319,190
R01 · FY2004 · CA
Cell Receptors In Coagulation And Atherogenesis$308,000
R01 · FY2004 · HL
Medical Scientist Training Program$1,547,332
T32 · FY2003 · GM
Modulation of Angiogenesis Via the Angiostatin Receptor$309,894
R01 · FY2003 · CA
Cell Receptors In Coagulation And Atherogenesis$308,000
R01 · FY2003 · HL
Alpha2-Macroglobulin-PA Complexes: Novel Anthrax Vaccin*$231,000
R21 · FY2003 · AI
Medical Scientist Training Program$1,440,033
T32 · FY2002 · GM
Modulation of Angiogenesis Via the Angiostatin Receptor$357,987
R01 · FY2002 · CA
Alpha2-Macroglobulin-PA Complexes: Novel Anthrax Vaccin*$231,000
R21 · FY2002 · AI
MEDICAL SCIENTIST TRAINING PROGRAM$1,224,414
T32 · FY2001 · GM
Modulation of Angiogenesis Via the Angiostatin Receptor$298,404
R01 · FY2001 · CA
CELL RECEPTORS IN COAGULATION AND ATHEROGENESIS$253,647
R37 · FY2001 · HL
Modulation of Angiogenesis Via the Angiostatin Receptor$50,820
R01 · FY2001 · CA
MEDICAL SCIENTIST TRAINING PROGRAM$1,225,901
T32 · FY2000 · GM
CELL RECEPTORS IN COAGULATION AND ATHEROGENESIS$247,985
R37 · FY2000 · HL